{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:53:36Z","timestamp":1788872016204,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","award":["PHD\/0241\/2553"],"award-info":[{"award-number":["PHD\/0241\/2553"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013238","name":"Faculty of Medicine Siriraj Hospital, Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.bcmd.2014.11.017","type":"journal-article","created":{"date-parts":[[2014,11,25]],"date-time":"2014-11-25T20:18:51Z","timestamp":1416946731000},"page":"286-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Acquired somatic mutations of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) in preleukemic disorders"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2893-5209","authenticated-orcid":false,"given":"Sadudee","family":"Chotirat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanna","family":"Thongnoppakhun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchai","family":"Wanachiwanawin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirayu U.","family":"Auewarakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9550","key":"10.1016\/j.bcmd.2014.11.017_bb0005","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(06)69780-8","article-title":"Acute myeloid leukaemia","volume":"368","author":"Estey","year":"2006","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.bcmd.2014.11.017_bb0010","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","article-title":"Acute myeloid leukemia","volume":"341","author":"Lowenberg","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bcmd.2014.11.017_bb0015","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1073\/pnas.1324297111","article-title":"Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission","volume":"111","author":"Corces-Zimmerman","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bcmd.2014.11.017_bb0020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/0008-5472.CAN-09-3783","article-title":"Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias","volume":"70","author":"Abdel-Wahab","year":"2010","journal-title":"Cancer Res."},{"issue":"5\u20136","key":"10.1016\/j.bcmd.2014.11.017_bb0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/10428199909058399","article-title":"Leukemia arising out of paroxysmal nocturnal hemoglobinuria","volume":"32","author":"Harris","year":"1999","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.bcmd.2014.11.017_bb0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ajh.23596","article-title":"IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution","volume":"89","author":"Lin","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.bcmd.2014.11.017_bb0035","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/leu.2010.113","article-title":"IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis","volume":"24","author":"Tefferi","year":"2010","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.bcmd.2014.11.017_bb0040","first-page":"459","article-title":"Preleukemia. Cytogenetic clues in some confusing disorders","volume":"89","author":"Nowell","year":"1977","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.bcmd.2014.11.017_bb0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.molmed.2010.07.002","article-title":"IDH mutations in glioma and acute myeloid leukemia","volume":"16","author":"Dang","year":"2010","journal-title":"Trends Mol. Med."},{"issue":"3","key":"10.1016\/j.bcmd.2014.11.017_bb0050","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1104\/pp.121.3.921","article-title":"Peroxisomal NADP-dependent isocitrate dehydrogenase. Characterization and activity regulation during natural senescence","volume":"121","author":"Corpas","year":"1999","journal-title":"Plant Physiol."},{"issue":"7274","key":"10.1016\/j.bcmd.2014.11.017_bb0055","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"issue":"5924","key":"10.1016\/j.bcmd.2014.11.017_bb0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1126\/science.1170944","article-title":"Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha","volume":"324","author":"Zhao","year":"2009","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bcmd.2014.11.017_bb0065","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","article-title":"The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate","volume":"17","author":"Ward","year":"2010","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bcmd.2014.11.017_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/humu.20937","article-title":"IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors","volume":"30","author":"Bleeker","year":"2009","journal-title":"Hum. Mutat."},{"issue":"5897","key":"10.1016\/j.bcmd.2014.11.017_bb0075","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.bcmd.2014.11.017_bb0080","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.bcmd.2014.11.017_bb0085","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1182\/blood-2009-11-253070","article-title":"Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation","volume":"115","author":"Chou","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bcmd.2014.11.017_bb0090","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1182\/blood-2009-11-250878","article-title":"Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value","volume":"116","author":"Abbas","year":"2010","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.bcmd.2014.11.017_bb0095","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1200\/JCO.2010.28.2285","article-title":"Prognostic impact of isocitrate dehydrogenase enzyme isoforms 1 and 2 mutations in acute myeloid leukemia: a study by the Acute Leukemia French Association group","volume":"28","author":"Boissel","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcmd.2014.11.017_bb0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-8722-5-5","article-title":"Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients","volume":"5","author":"Chotirat","year":"2012","journal-title":"J. Hematol. Oncol."},{"issue":"14","key":"10.1016\/j.bcmd.2014.11.017_bb0105","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1200\/JCO.2009.27.6899","article-title":"Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor","volume":"28","author":"Wagner","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.bcmd.2014.11.017_bb0110","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/leu.2010.52","article-title":"Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS\/myeloproliferative neoplasms","volume":"24","author":"Kosmider","year":"2010","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.bcmd.2014.11.017_bb0115","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.3324\/haematol.2010.025494","article-title":"IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis","volume":"95","author":"Thol","year":"2010","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.bcmd.2014.11.017_bb0120","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/leu.2010.98","article-title":"Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q)","volume":"24","author":"Pardanani","year":"2010","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.bcmd.2014.11.017_bb0125","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/leu.2010.77","article-title":"IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms","volume":"24","author":"Pardanani","year":"2010","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.bcmd.2014.11.017_bb0130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMc0910063","article-title":"Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms","volume":"362","author":"Green","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bcmd.2014.11.017_bb0135","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","article-title":"Recurring mutations found by sequencing an acute myeloid leukemia genome","volume":"361","author":"Mardis","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.bcmd.2014.11.017_bb0140","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1200\/JCO.2010.28.3762","article-title":"IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication","volume":"28","author":"Paschka","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"25","key":"10.1016\/j.bcmd.2014.11.017_bb0145","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1182\/blood-2010-02-267955","article-title":"IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60years and unmutated NPM1 status","volume":"116","author":"Schnittger","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bcmd.2014.11.017_bb0150","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1751-553X.2012.01422.x","article-title":"IDH2 mutations are frequent in Chinese patients with acute myeloid leukemia and associated with NPM1 mutations and FAB-M2 subtype","volume":"34","author":"Chao","year":"2012","journal-title":"Int. J. Lab. Hematol."},{"issue":"26","key":"10.1016\/j.bcmd.2014.11.017_bb0155","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical effect of point mutations in myelodysplastic syndromes","volume":"364","author":"Bejar","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bcmd.2014.11.017_bb0160","doi-asserted-by":"crossref","first-page":"e100206","DOI":"10.1371\/journal.pone.0100206","article-title":"Prognostic value of isocitrate dehydrogenase mutations in myelodysplastic syndromes: a retrospective cohort study and meta-analysis","volume":"9","author":"Jin","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bcmd.2014.11.017_bb0165","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00277-011-1352-7","article-title":"IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome","volume":"91","author":"Lin","year":"2012","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.bcmd.2014.11.017_bb0170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3324\/haematol.2013.091249","article-title":"Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1\/2 mutations","volume":"99","author":"Lin","year":"2014","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.bcmd.2014.11.017_bb0175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/leu.2011.298","article-title":"Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patients","volume":"26","author":"Patnaik","year":"2012","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.bcmd.2014.11.017_bb0180","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/leu.2010.105","article-title":"WHO-defined \u2018myelodysplastic syndrome with isolated del(5q)\u2019 in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations","volume":"24","author":"Patnaik","year":"2010","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.bcmd.2014.11.017_bb0185","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/leu.2011.253","article-title":"IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F","volume":"26","author":"Tefferi","year":"2012","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.bcmd.2014.11.017_bb0190","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/ijc.24469","article-title":"The impact of JAK2 non-receptor tyrosine kinase mutation on the mobilization of hematopoietic stem cells into peripheral blood of patients with Philadelphia chromosome-negative myeloproliferative disorders","volume":"125","author":"Kannim","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"23","key":"10.1016\/j.bcmd.2014.11.017_bb0195","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1182\/blood-2010-06-290791","article-title":"IDH mutation analysis is not suitable for the routine molecular diagnostic algorithm in myeloproliferative and myelodysplastic neoplasms","volume":"116","author":"Hussein","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcmd.2014.11.017_bb0200","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbrc.2010.10.038","article-title":"IDH1 and IDH2 mutations are frequent in Chinese patients with acute myeloid leukemia but rare in other types of hematological disorders","volume":"402","author":"Zou","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.bcmd.2014.11.017_bb0205","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation","volume":"18","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bcmd.2014.11.017_bb0210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.bcmd.2014.11.017_bb0215","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1182\/blood-2013-03-493197","article-title":"Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia","volume":"121","author":"DiNardo","year":"2013","journal-title":"Blood"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979614001508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979614001508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:30:47Z","timestamp":1761049847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979614001508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1079979614001508"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.11.017","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired somatic mutations of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) in preleukemic disorders","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}